Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 13
2004 7
2005 10
2006 10
2007 16
2008 15
2009 15
2010 10
2011 15
2012 14
2013 10
2014 13
2015 11
2016 11
2017 9
2018 10
2019 15
2020 10
2021 11
2022 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, Benson AB 3rd; Eastern Cooperative Oncology Group Study E3200. Giantonio BJ, et al. Among authors: meropol nj. J Clin Oncol. 2007 Apr 20;25(12):1539-44. doi: 10.1200/JCO.2006.09.6305. J Clin Oncol. 2007. PMID: 17442997 Corrected and republished. Clinical Trial.
Esophageal cancer.
Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Swisher SG, Washington MK, Willett C, Wood DE, Wright CD, Yang G; NCCN Esophageal Cancer Panel. Ajani JA, et al. Among authors: meropol nj. J Natl Compr Canc Netw. 2008 Oct;6(9):818-49. J Natl Compr Canc Netw. 2008. PMID: 18926093 No abstract available.
Implementing an Electronic End-of-Life Chemotherapy Utilization Measure.
Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, Meropol NJ. Kraut J, et al. Among authors: meropol nj. J Oncol Pract. 2019 Apr;15(4):220-223. doi: 10.1200/JOP.18.00408. Epub 2019 Mar 18. J Oncol Pract. 2019. PMID: 30883256 No abstract available.
A renewed call for equipoise.
Meropol NJ. Meropol NJ. J Clin Oncol. 2007 Aug 10;25(23):3392-4. doi: 10.1200/JCO.2007.11.9503. J Clin Oncol. 2007. PMID: 17687146 No abstract available.
Cost of cancer care: issues and implications.
Meropol NJ, Schulman KA. Meropol NJ, et al. J Clin Oncol. 2007 Jan 10;25(2):180-6. doi: 10.1200/JCO.2006.09.6081. J Clin Oncol. 2007. PMID: 17210937 Review.
A new era for the systemic therapy of neuroendocrine tumors.
Eads JR, Meropol NJ. Eads JR, et al. Among authors: meropol nj. Oncologist. 2012;17(3):326-38. doi: 10.1634/theoncologist.2011-0356. Epub 2012 Feb 21. Oncologist. 2012. PMID: 22357730 Free PMC article. Review.
Ongoing challenge of stage II colon cancer.
Meropol NJ. Meropol NJ. J Clin Oncol. 2011 Sep 1;29(25):3346-8. doi: 10.1200/JCO.2011.35.4571. Epub 2011 Jul 25. J Clin Oncol. 2011. PMID: 21788557 No abstract available.
220 results